Invasion of v-FosFBR-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes

Oncogene

Volumn 23, Issue 31, 2004, Pages 5284-5292

  McGarry, Lynn C ^a   Winnie, Joseph N ^a   Ozanne, Bradford W ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Deacetylase; Fos; Invasion; Protocadherin; RYBP; STAT6

Indexed keywords

CADHERIN; HISTONE DEACETYLASE; PROTEIN V FOS; STAT6 PROTEIN; TRICHOSTATIN A; VALPROIC ACID; ACTIN; GAMMA PROTOCADHERINS; GAMMA-PROTOCADHERINS; HYDROXAMIC ACID; REPRESSOR PROTEIN; RNA; RYBP PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMOTAXIS; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; ONCOGENE; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CANCER INVASION; CELL DIVISION; CELL LINE; CELL MOTION; CONFOCAL MICROSCOPY; DOSE RESPONSE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; METABOLISM; MOLECULAR CLONING; NORTHERN BLOTTING; PHASE CONTRAST MICROSCOPY; PHENOTYPE; RAT; WESTERN BLOTTING;

ACTINS; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CADHERINS; CELL DIVISION; CELL LINE; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CHEMOTAXIS; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; MICROSCOPY, CONFOCAL; MICROSCOPY, PHASE-CONTRAST; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS V-FOS; PHENOTYPE; RATS; REPRESSOR PROTEINS; RNA; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION; VALPROIC ACID;

EID: 3142702962     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207687     Document Type: Article

References (38)

1. Bakin AV and Curran T. (1999). Science, 283, 387-390.
2. Buttner C, Skupin A and Rieber EP. (2004). J Cell Physiol, 198, 248-258.
3. Eferl R and Wagner E. (2003), Nat Rev Cancer, 3, 859-868.
4. Garcia E, Marcos-Gutierrez C, del Mar Lorente M, Moreno JC and Vidal M. (1999). EMBO J, 18, 3404-3418.
5. Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG and Heinzel T. (2001). EMBO J, 20, 6969-6978.
6. Grunstein M. (1997). Nature, 389, 349-352.
7. Hennigan RF, Hawker KL and Ozanne BW. (1994). Oncogene, 9, 3591-3600.
8. Imai T, Adachi S, Nishijo K, Ohgushi M, Okada M, Yasumi T, Watanabe K, Nishikomori R, Nakayama T, Yonehara S, Toguchida J and Nakahata T. (2003). Oncogene, 22, 9231-9242.
9. Johnston IM, Spence HJ, Winnie JN, McGarry L, Vass JK, Meagher L, Stapleton G and Ozanne BW. (2000). Oncogene, 19, 5348-5358.
10. Kelly WK, O'Connor OA and Marks PA. (2002). Expert Opin Invest Drugs, 11, 1695-1713.
11. Kouzarides T. (2000). EMBO J, 19, 1176-1179.
12. Kuo MH and Allis CD. (1998). Bioessays, 20, 615-626.
13. Kwon HJ, Owa T, Hassig CA, Shimada J and Schreiber SL. (1998). Proc Natl Acad Sci USA, 95, 3356-3361.
14. Lamb RF, Hennigan RF, Turnbull K, Katsanakis KD, MacKenzie ED, Birnie GD and Ozanne BW. (1997a). Mol Cell Biol, 17, 963-976.
15. Lamb RF, Ozanne BW, Roy C, McGarry L, Stipp C, Mangeat P and Jay DG. (1997b). Curr Biol, 7, 682-688.
16. Lehrmann H, Pritchard LL and Harel-Bellan A. (2002). Adv Cancer Res, 86, 41-65.
17. Liu LT, Chang HC, Chiang LC and Hung WC. (2003). Cancer Res, 63, 3069-3072.
18. Marks PA, Miller T and Richon VM. (2003). Curr Opin Pharmacol, 3, 344-351.
19. Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, Kami K, Mori T, Wada M, Noda M and Imamura M. (2003). Clin Cancer Res, 9, 1779-1784.
20. Matsumoto M, Matsutani S, Sugita K, Yoshida H, Hayashi F, Terui Y, Nakai H, Uotani N, Kawamura Y, Matsumoto K, Shoji J and Yoshida T. (1992). J Antibiotics (Tokyo), 45, 879-885.
21. McGaha TL, Le M, Kodera T, Stoica C, Zhu J, Paul WE and Bona CA. (2003). Arthritis Rheum, 48, 2275-2284.
22. Ozanne BW, McGarry L, Spence HJ, Johnston I, Winnie J, Meagher L and Stapleton G. (2000). Eur J Cancer, 36, 1640-1648.
23. Quelle FW, Shimoda K, Thierfelder W, Fischer C, Kim A, Ruben SM, Cleveland JL, Pierce JH, Keegan AD, Nelms K, Paul WE and Ihle JN. (1995). Mol Cell Biol, 15, 3336-3343.
24. Rosato RR, Almenara JA and Grant S. (2003). Cancer Res, 63, 3637-3645.
25. Sambrook J, Fritsch EF and Maniatis T. (1989). Molecular Cloning. A Laboratory Manual, 2 edn Cold Spring Harbour Laboratory Press: Cold Spring Harbor, NY.
26. Sano K, Tanihara H, Heimark RL, Obata S, Davidson M, St John T, Taketani S and Suzuki S. (1993). EMBO J, 12, 2249-2256.
27. Schlisio S, Halperin T, Vidal M and Nevins JR. (2002). EMBO J, 21, 5775-5786.
28. Scott LA, Vass JK, Parkinson EK, Gillespie DAF, Winnie JN and Ozanne BW. (2004). Mol Cell Biol, 24, 1540-1559.
29. Spence HJ, Johnston I, Ewart K, Buchanan SJ, Fitzgerald U and Ozanne BW. (2000). Oncogene, 19, 1266-1276.
30. Stapleton G, Malliri A and Ozanne BW. (2002). J Cell Sci, 115, 2713-2724.
31. Sugita K, Yoshida H, Matsumoto M and Matsutani S. (1992). Biochem Biophys Res Commun, 182, 379-387.
32. Suzuki ST. (2000). Exp Cell Res, 261, 13-18.
33. Timmermann S, Lehrmann H, Polesskaya A and Harel-Bellan A. (2001). Cell Mol Life Sci, 58, 728-736.
34. Trimarchi JM, Fairchild B, Wen J and Lees JA. (2001). Proc Natl Acad Sci USA, 98, 1519-1524.
35. Yamashita Y, Shimada M, Harimoto N, Rikimaru T, Shirabe K, Tanaka S and Sugimachi K. (2003). Int J Cancer, 103, 572-576.
36. Yoshida M, Kijima M, Akita M and Beppu T. (1990). J Biol Chem, 265, 17174-17179.
37. Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P and Reinberg D. (1997). Cell, 89, 357-364.
38. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A and Reinberg D. (1999). Genes Dev, 13, 1924-1935.